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Introduction
Although infarct size by late gadolinium enhancement
(LGE) CMR imaging is a robust prognostic marker in
patients with recent MI, long scan times and repeated
breathholds associated with the current standard, single-
slice 2D multiple-breathhold (SS2D), limit clinical use of
this technique. Two new techniques, whole-heart 2D sin-
gle-breathhold (WHOLE) and navigator-guided 3D free-
breathing (3DNAV), offer the advantages of decreased
scan time and higher spatial resolution without breath-
holding, respectively.
Purpose
Since the measurement of infarct size by these techniques
has not been compared, we sought to test the hypothesis
that the WHOLE and 3DNAV techniques provide accurate
quantification of infarct size when compared to the stand-
ard SS2D technique.
Methods
We prospectively enrolled 56 patients (43 men and 13
women, mean age 61 ± 10.7 years) to perform 3 T CMR
(Siemens Trio) within eight weeks of revascularized acute
MI. With each of the three techniques, LGE size was quan-
tified in a blinded fashion using signal intensity criteria
(1) at full width at half maximum (FWHM), (2) > 3SD,
and (3) > 2SD beyond the mean signal intensity of nor-
mal myocardium.
Results
The mean peak troponin was 61.2 ± 65.4 ng/mL and the
mean LVEF was 47.7 ± 11.0%. We found that myocardial
infarct sizes obtained with the WHOLE and 3DNAV tech-
niques are highly correlated with results obtained by the
standard SS2D technique (r = 0.95-0.97 and r = 0.91-0.96,
respectively), across the three common infarct sizing sig-
nal intensity threshold criteria. Bland-Altman analysis
demonstrated excellent inter-technique agreement (Figure
1).
Conclusion
The WHOLE and 3DNAV techniques provide accurate
quantification of infarct size when compared to the stand-
ard SS2D technique. Use of these techniques in the clini-
cal setting could improve patient tolerability or spatial
resolution.
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